BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 8, 2013
View Archived Issues
Consortium developing placental malaria vaccine receives E.U. grant
Read More
Dr. Reddy's Laboratories presents new series of CETP inhibitors
Read More
Glenmark Pharmaceuticals presents new ITK/TSK inhibitors
Read More
Alzheimer's Drug Discovery Foundation awards grant for novel peptide research
Read More
HUYA Bioscience enters collaboration with Zhangjiang Biotech Pharmaceutical Base
Read More
Senesco takes steps to accelerate enrollment in phase Ib/IIa study of anticancer candidate
Read More
SynapDx and Illumina join to develop early detection tools for autism
Read More
Galapagos achieves milestones in Servier alliances
Read More
Pfizer presents promising phase IIa results for topical tofacitinib in plaque psoriasis
Read More
Phase II study of palifosfamide in incurable germ cell tumors begins
Read More
First patient enrolled in third phase III study of laquinimod in multiple sclerosis
Read More
Novogen signs memorandum of understanding with The Ingham Institute
Read More
VAC-3S immunotherapeutic proves safe and well tolerated in HIV-1
Read More
Cylene and TetraGene enter exclusive worldwide agreement for anticancer candidate
Read More
Genentech presents phase I results for GDC-0068
Read More
Second Sight's Argus II Retinal Prosthesis implanted in first patients in the Middle East
Read More
KM-023 demonstrates good tolerance and pharmacokinetics in a phase I trial
Read More
Athera Biotechnologies and Dyax patent novel antibodies
Read More
Gervais Danone discloses new bacterial strains for infections
Read More
Researchers at Two to Biotech divulge new peptides
Read More
Maximum tolerated dose defined in CH-5132799 study
Read More
Japanese launch of Cimzia for rheumatoid arthritis
Read More
GSK files for European approval of albiglutide
Read More
Janssen files MAA for fixed-dose combination of canagliflozin and metformin
Read More
DSP and Nippon Shinyaku sign Japanese agreement for SMP-986
Read More
U.K. approval for Duexis for osteoarthritis, rheumatoid arthritis and ankylosing spondylitis
Read More